Trial NCT04191382

View at ClinicalTrials.gov 
Org. Study IDs: ACT16106
Secondary IDs: 2019-002015-26 U1111-1228-9473

Last trial update was posted on 2022-06-29

MeSH Interventions

Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

early discontinuation based on strategic sponsor decision not driven by any safety concerns

Limitations And Caveats

The study recruitment discontinued early based on strategic sponsor decision that was not driven by any safety concerns. No inferential statistical analysis was performed due to early termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID